6 Jul 2012 07:00
AIM: ODX
OMEGA DIAGNOSTICS GROUP PLC
("Omega" or the "Company)
Grant of Options
Omega, the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that its Remuneration Committee on 5 July 2012 awarded the following director share options:
Options granted 5 July 2012 | Total options following grant
| |||
Andrew Shepherd | 600,000 | 1,303,480 | ||
Kieron Harbinson | 300,000 | 768,987 | ||
Jag Grewal | 200,000 | 300,000 |
All options are awarded under the Company's EMI Share Option Scheme. The options have a three year vesting period, have been awarded at an exercise price of 14.5p (closing mid market price on 4 July 2012) and after they are fully vested, there is a performance criteria that they cannot be exercised until the share price is at 25p or higher.
Contacts:
Omega Diagnostics Group PLC | Tel: 01259 763 030 |
Kieron Harbinson, Group Finance Director | www.omegadiagnostics.com |
Seymour Pierce Group | Tel: 020 7107 8000 www.seymourpierce.com |
Freddy Crossley / Mark Percy (Corporate Finance) David Banks / Katie Ratner (Corporate Broking) | |
Walbrook PR Limited | |
Paul McManus | Tel: 020 7933 8787 Mob: 07980 541 893 paul.mcmanus@walbrookpr.com
|
Paul Cornelius | Tel: 020 7933 8794 |
Mob: 07886 384 707 | |
paul.cornelius@walbrookpr.com |
ODX.L (ODX)